Western blots showed the consistent over-expressed of MBL2 and MLCK2 in individual pancreatic cancer patients compared with individual non-cancer-bearing donors (n = 16), and the Figure 3 showed the western blot results of 16 pairs of the pancreatic cancer sera and non-cancer-bearing controls' sera. Here, MYLK2 is linked to familial pancreatic carcinoma.